| 000 | 01676 a2200505 4500 | ||
|---|---|---|---|
| 005 | 20250512021200.0 | ||
| 264 | 0 | _c19891219 | |
| 008 | 198912s 0 0 eng d | ||
| 022 | _a0021-5198 | ||
| 024 | 7 |
_a10.1254/jjp.51.57 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aOizumi, K | |
| 245 | 0 | 0 |
_aAntihypertensive effects of CS-905, a novel dihydropyridine Ca++ channel blocker. _h[electronic resource] |
| 260 |
_bJapanese journal of pharmacology _cSep 1989 |
||
| 300 |
_a57-64 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 | _aAnesthesia |
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 | _aAntihypertensive Agents |
| 650 | 0 | 4 |
_aAorta _xdrug effects |
| 650 | 0 | 4 |
_aAzetidinecarboxylic Acid _xanalogs & derivatives |
| 650 | 0 | 4 |
_aAzetines _xpharmacology |
| 650 | 0 | 4 |
_aBlood Pressure _xdrug effects |
| 650 | 0 | 4 |
_aCalcium Channel Blockers _xpharmacology |
| 650 | 0 | 4 | _aDesoxycorticosterone |
| 650 | 0 | 4 |
_aDihydropyridines _xpharmacology |
| 650 | 0 | 4 |
_aHeart Rate _xdrug effects |
| 650 | 0 | 4 |
_aHypertension _xchemically induced |
| 650 | 0 | 4 |
_aHypertension, Renal _xdrug therapy |
| 650 | 0 | 4 | _aIn Vitro Techniques |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aMuscle Contraction _xdrug effects |
| 650 | 0 | 4 |
_aMuscle, Smooth, Vascular _xdrug effects |
| 650 | 0 | 4 | _aNephrectomy |
| 650 | 0 | 4 | _aRats |
| 650 | 0 | 4 | _aRats, Inbred SHR |
| 650 | 0 | 4 | _aRats, Inbred Strains |
| 700 | 1 | _aNishino, H | |
| 700 | 1 | _aKoike, H | |
| 700 | 1 | _aSada, T | |
| 700 | 1 | _aMiyamoto, M | |
| 700 | 1 | _aKimura, T | |
| 773 | 0 |
_tJapanese journal of pharmacology _gvol. 51 _gno. 1 _gp. 57-64 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1254/jjp.51.57 _zAvailable from publisher's website |
| 999 |
_c2816807 _d2816807 |
||